Epidemic strain Shigella dysenteriae Type 1 Dt66 encodes several drug resistances by chromosome

Dipak Kumar Hens1, Swapan Kumar Niyogi, Ranajit Kumar

  • 1National Institute of Cholera and Enteric Diseases, Beliaghata Kolkata, India.

Abstract

Insights

Seventy percent of drug resistance in Shigella dysenteriae type 1 is chromosomally encoded, not plasmid-mediated. This finding is crucial for understanding and treating multi-drug resistant bacterial infections.

Area of Science:

  • Microbiology
  • Genetics
  • Infectious Diseases

Background:

  • Multiple antibiotic-resistant Shigella dysenteriae type 1 strains emerged during a 1984 epidemic in West Bengal, India.
  • Previous research focused on treatment recommendations, with limited data on chromosomal drug resistance.
  • Understanding the genetic basis of resistance is vital for combating infectious diseases.

Purpose of the Study:

  • To investigate the genetic basis of antibiotic resistance in epidemic Shigella dysenteriae type 1 strains.
  • To differentiate between chromosomal and plasmid-mediated drug resistance.
  • To provide data for reevaluating treatment strategies against resistant bacterial pathogens.

Main Methods:

  • Isolation and biochemical/serological identification of 300 Shigella dysenteriae type 1 strains.
  • Antibiotic susceptibility testing using disk diffusion and plasmid DNA analysis.
  • Plasmid curing with acridine orange, followed by Pulsed-Field Gel Electrophoresis (PFGE) and Southern blot hybridization.

Main Results:

  • All isolates exhibited identical resistance patterns and plasmid profiles, containing six plasmids (3-145 kb).
  • Twelve of 17 antibiotic resistances were chromosomally encoded, while five were plasmid-mediated.
  • Southern blot revealed genetic homology between chromosomal and plasmid DNA, with PFGE confirming strain stability.

Conclusions:

  • The chromosome of Shigella dysenteriae type 1 Dt66 harbors 70% of drug resistance loci.
  • Plasmid-mediated resistance accounts for the remaining 30% of drug resistance.
  • This highlights the significant role of chromosomal genes in the evolution of multi-drug resistant bacteria.

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Genomic DNA in Prokaryotes00:46

Genomic DNA in Prokaryotes

The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...